PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Novavax’s CEO reviewed the company’s successes in 2025 and shared its growth strategy for 2026 and beyond at a recent conference.
DG Matrix announces the first field deployment of its breakthrough Power Router technology to accelerate global electrification and alleviate grid constraints. In a bold move to leapfrog the entire ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results